The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
108822027 10882202 7 F 201501 20160707 20150303 20160718 EXP US-CELGENEUS-USA-2015024348 CELGENE 75.58 YR M Y 88.53000 KG 20160718 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
108822027 10882202 1 PS THALOMID THALIDOMIDE 1 Oral U B0021AA,B2005AA 20785 200 MG CAPSULES QD
108822027 10882202 2 SS THALOMID THALIDOMIDE 1 Oral U B0021AA,B2005AA 20785 100 MG CAPSULES QD
108822027 10882202 3 SS THALOMID THALIDOMIDE 1 Oral U B0021AA,B2005AA 20785 100 MG CAPSULES QD
108822027 10882202 4 SS THALOMID THALIDOMIDE 1 Oral U B0021AA,B2005AA 20785 100 MG CAPSULES
108822027 10882202 5 C GLIPIZIDE. GLIPIZIDE 1 Unknown 0 5 MG UNKNOWN
108822027 10882202 6 C PLAVIX CLOPIDOGREL BISULFATE 1 Unknown 0 75 MG UNKNOWN
108822027 10882202 7 C LUMIGAN BIMATOPROST 1 Ophthalmic 0 SOLUTION
108822027 10882202 8 C Metformin HCl METFORMIN HYDROCHLORIDE 1 Oral 0 500 MG TABLETS
108822027 10882202 9 C ATENOLOL. ATENOLOL 1 Unknown 65-25 MG 0 UNKNOWN
108822027 10882202 10 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 0 20 MG TABLETS
108822027 10882202 11 C Triamterene/Hydrochlorothiazide HYDROCHLOROTHIAZIDETRIAMTERENE 1 Oral 37.5-25 0 CAPSULES
108822027 10882202 12 C Insulin INSULIN NOS 1 Unknown 0 UNKNOWN
108822027 10882202 13 C ASPIRIN. ASPIRIN 1 Unknown 0 UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
108822027 10882202 1 Plasma cell myeloma
108822027 10882202 5 Product used for unknown indication
108822027 10882202 6 Product used for unknown indication
108822027 10882202 7 Product used for unknown indication
108822027 10882202 8 Product used for unknown indication
108822027 10882202 9 Product used for unknown indication
108822027 10882202 10 Product used for unknown indication
108822027 10882202 11 Product used for unknown indication
108822027 10882202 12 Product used for unknown indication
108822027 10882202 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
108822027 10882202 OT
108822027 10882202 LT
108822027 10882202 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
108822027 10882202 Arterial rupture
108822027 10882202 Cerebrovascular accident
108822027 10882202 Diabetes mellitus inadequate control
108822027 10882202 Diarrhoea
108822027 10882202 Gout
108822027 10882202 Thrombosis
108822027 10882202 Vascular dementia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
108822027 10882202 1 200809 0
108822027 10882202 2 200902 0
108822027 10882202 3 20101105 0
108822027 10882202 4 20130125 0